Literature DB >> 91022

Fish-eye disease. A new familial condition with massive corneal opacities and dyslipoproteinaemia.

L A Carlson, B Philipson.   

Abstract

A man and his three daughters had massive corneal opacities called in their home village "fish-eye disease" because of the resemblance of the eyes to those of boiled fish. The two living daughters had the same dyslipoproteinaemia, characterised by normal serum cholesterol but raised serum triglycerides, raised very-low-density lipoproteins, strikingly high levels of low-density lipoprotein (LDL) triglycerides. LDL contained normal sized as well as abnormally large particles and a 90% reduction in the level of high-density lipoprotein (HDL) cholesterol. Lecithin:cholesterol acyltransferase (LCAT) activity and the percentage of plasma cholesterol esters were normal, with excluded LCAT-deficiency. Normal electrophoretic mobility of HDL as well as other lipoprotein findings excluded Tangier disease. The clinical and laboratory abnormalities in fish-eye disease are atherosclerosis at old age, visual impairment, and dense corneal opacification. Fish-eye disease thus differs both clinically and in its lipoprotein abnormalities from LCAT-deficiency and Tangier disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91022

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

1.  A woman with low HDL cholesterol and corneal opacity.

Authors:  Tiziano Lucchi; Laura Calabresi; Angela Pinto; Elisa Benetti; Beatrice Arosio; Sara Simonelli; Roberto Ratiglia; Carlo Vergani
Journal:  Intern Emerg Med       Date:  2011-10-29       Impact factor: 3.397

Review 2.  Indications for lipid-lowering drugs.

Authors:  J Davignon
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.

Authors:  Hiroyuki Tanigawa; Jeffrey T Billheimer; Jun-ichiro Tohyama; Ilia V Fuki; Dominic S Ng; George H Rothblat; Daniel J Rader
Journal:  Circulation       Date:  2009-06-29       Impact factor: 29.690

4.  Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency.

Authors:  Satoshi Takahashi; Keiju Hiromura; Mayuko Tsukida; Yuko Ohishi; Hiroko Hamatani; Noriyuki Sakurai; Toru Sakairi; Hidekazu Ikeuchi; Yoriaki Kaneko; Akito Maeshima; Takashi Kuroiwa; Hideaki Yokoo; Takeo Aoki; Michio Nagata; Yoshihisa Nojima
Journal:  J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 10.121

5.  A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.

Authors:  G Franceschini; C R Sirtori; A Capurso; K H Weisgraber; R W Mahley
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

6.  A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein.

Authors:  Xiaodong Gu; Zhiping Wu; Ying Huang; Matthew A Wagner; Camelia Baleanu-Gogonea; Ryan A Mehl; Jennifer A Buffa; Anthony J DiDonato; Leah B Hazen; Paul L Fox; Valentin Gogonea; John S Parks; Joseph A DiDonato; Stanley L Hazen
Journal:  J Biol Chem       Date:  2016-01-21       Impact factor: 5.157

Review 7.  Familial LCAT deficiency and fish-eye disease.

Authors:  N McIntyre
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

Review 8.  Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?

Authors:  Sandra Kunnen; Miranda Van Eck
Journal:  J Lipid Res       Date:  2012-05-07       Impact factor: 5.922

9.  Genetic and secondary causes of severe HDL deficiency and cardiovascular disease.

Authors:  Andrew S Geller; Eliana Y Polisecki; Margaret R Diffenderfer; Bela F Asztalos; Sotirios K Karathanasis; Robert A Hegele; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2018-10-17       Impact factor: 5.922

10.  A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins.

Authors:  K H Weisgraber; T P Bersot; R W Mahley; G Franceschini; C R Sirtori
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.